HomeCompareBYLTF vs JNJ

BYLTF vs JNJ: Dividend Comparison 2026

BYLTF yields 1031.46% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BYLTF wins by $24699148.56M in total portfolio value
10 years
BYLTF
BYLTF
● Live price
1031.46%
Share price
$0.19
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24699148.59M
Annual income
$20,743,118,098,407.43
Full BYLTF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — BYLTF vs JNJ

📍 BYLTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBYLTFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BYLTF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BYLTF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BYLTF
Annual income on $10K today (after 15% tax)
$87,674.06/yr
After 10yr DRIP, annual income (after tax)
$17,631,650,383,646.32/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, BYLTF beats the other by $17,631,650,379,660.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BYLTF + JNJ for your $10,000?

BYLTF: 50%JNJ: 50%
100% JNJ50/50100% BYLTF
Portfolio after 10yr
$12349574.31M
Annual income
$10,371,559,051,548.41/yr
Blended yield
83.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BYLTF
No analyst data
Altman Z
-5.1
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BYLTF buys
0
JNJ buys
0
No recent congressional trades found for BYLTF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBYLTFJNJ
Forward yield1031.46%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$24699148.59M$30.3K
Annual income after 10y$20,743,118,098,407.43$4,689.40
Total dividends collected$24398173.42M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BYLTF vs JNJ ($10,000, DRIP)

YearBYLTF PortfolioBYLTF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$113,846$103,145.95$10,592$272.30+$103.3KBYLTF
2$1,219,268$1,097,453.18$11,289$357.73+$1.21MBYLTF
3$12,289,209$10,984,591.99$12,123$472.89+$12.28MBYLTF
4$116,621,917$103,472,463.22$13,141$629.86+$116.61MBYLTF
5$1,042,478,098$917,692,646.52$14,408$846.81+$1042.46MBYLTF
6$8,782,006,243$7,666,554,678.34$16,021$1,151.60+$8781.99MBYLTF
7$69,755,917,071$60,359,170,391.34$18,122$1,588.22+$69755.90MBYLTF
8$522,709,788,987$448,070,957,720.61$20,930$2,228.20+$522709.77MBYLTF
9$3,697,224,757,719$3,137,925,283,502.65$24,792$3,191.91+$3697224.73MBYLTF
10$24,699,148,589,166$20,743,118,098,407.43$30,274$4,689.40+$24699148.56MBYLTF

BYLTF vs JNJ: Complete Analysis 2026

BYLTFStock

Baylin Technologies Inc., together with its subsidiaries, researches, designs, develops, manufactures, and sells passive and active radio frequency (RF) products, satellite communications products, and supporting services. It offers embedded antennas for use in smartphones, tablets, and other mobile devices; device-specific antennas for Wi-Fi routers; gateway devices for smart home connectivity, set-top boxes, and land mobile radio products; and indoor and outdoor distributed antenna systems (DAS), small cell system antennas, and base station antennas (BSA) for original equipment manufacturer, DAS, BSA, and small cell markets. The company also provides RF components, including GaN-based power amplifiers, gallium arsenide-based power amplifiers, indoor and outdoor frequency converters, and transceivers; microwave components comprising point-to-point microwave radios and network management software; fixed and mobile antennas, and antenna controllers for customers in the broadcast, maritime and cruise ships, government and military, homeland security, direct-to-home satellite, oil and gas, and wireless communications verticals. In addition, it offers RF and microwave solid state power amplifiers; and pulsed amplifiers for radar applications, and transmitter and transceiver products, as well as RF passive components and systems. The company offers its products under the Galtronics, Advantech Wireless, Alga Microwave, and Mitec VSAT brands. It operates in the United States, Vietnam, China, India, Thailand, South Korea, Canada, Sweden, Indonesia, Hungary, Taiwan, Philippines, Portugal, Romania, Japan, Brazil, Israel, Singapore, Australia, France, Germany, Russia, and internationally. The company was founded in 1978 and is headquartered in Toronto, Canada.

Full BYLTF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this BYLTF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BYLTF vs SCHDBYLTF vs JEPIBYLTF vs OBYLTF vs KOBYLTF vs MAINBYLTF vs ABBVBYLTF vs MRKBYLTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.